Driving Pharma Launch Success Through Strategic Resourcing and Investment
CHAPEL HILL, N.C., Dec. 13, 2024/ -- In today's competitive biopharma landscape, organizations need to strategically allocate resources to various launch activities to meet shifting stakeholder demands and capture market share.
An effective product launch hinges on three key factors: strategic positioning, proactive stakeholder engagement, and well-timed resourcing of commercial and medical efforts.
What are the key investment benchmarks for a successful pharmaceutical product launch?
According to our study, funding for
market access and
HEOR tends to
rise significantly 24 to 36 months post-launch. In contrast, spending on
samples, sales force preparation, and
launch meetings tends to
decrease during the same timeframe.
The report, titled "Winning Necessary Resources for a Successful Product Launch," engaged 48 commercial leaders from 38 companies, leveraging data from 51 product launches to develop competitive budgets for launch and pre-launch activities, equipping you with the tools for a strong market entry.
The report’s focus areas include:
- Industry investments for new pharmaceutical product launch from 3 years prior to launch, through launch year
- Budget allocation to 12 key marketing, education and market access activities during and prior to launch
- Investment timing for conducting 50+ activities
- FTE allocated to key launch activities
- Anticipated budget and activity trends
- Top success factors
For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw422.htm
Pressed for time? A short video summary of the key insights is available to provide an overview of the report's main recommendations: